CODY MANLEY: Open Payments
NPI 1366119083 · CLINTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$569 in 29 payments from 11 companies in 2025. Trend: 2023 $650 · 2024 $1,579 · 2025 $569
Food & beverage: $569
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $159 |
| Novo Nordisk Inc | 10 | $136 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| ABBVIE INC. | 3 | $52 |
| Exact Sciences Corporation | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
Products named: AIRSUPRA, AUSTEDO XR, Wegovy, FARXIGA, Ozempic, VRAYLAR, Cologuard Collection Kit, LEQVIO.
Industry payments across IN — which companies pay providers there.
